U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
1875118751Does Icodextrin Reduce the Risk of Small Bowel Obstruction?RecruitingNo Results AvailableSurgical AdhesionsProcedure: Surgery|Drug: Icodextrinhttps://ClinicalTrials.gov/show/NCT02318888
1875218752Investigation of Kritech Efficacy on Subjects Having Functional Discomfort Associated to Joints and Muscles DisordersCompletedNo Results AvailablePainDietary Supplement: Kritech administration|Other: Placebo adminstrationhttps://ClinicalTrials.gov/show/NCT02318875
1875318753Assessment of Esophageal Epithelium Integrity With Mucosal ImpedanceActive, not recruitingNo Results AvailableGastroesophageal Reflux Disease (GERD)|Non-erosive Reflux Disease (NERD)Procedure: Standard of Care esophagogastroduodenoscopy (EGD) with mucosal impedance testinghttps://ClinicalTrials.gov/show/NCT02318862
1875418754Online Intervention for ANHPI College StudentsRecruitingNo Results AvailableTissue and Organ ProcurementBehavioral: Web interventionhttps://ClinicalTrials.gov/show/NCT02318849
1875518755Single-Dose Pharmacokinetics and Safety of Oral Lofexidine in Hepatically-Impaired SubjectsCompletedNo Results AvailableLiver FailureDrug: Lofexidine Hydrochloride (HCl) tabletshttps://ClinicalTrials.gov/show/NCT02318836
1875618756Effects of Beer (Alcohol) on Social CognitionCompletedNo Results AvailableHealthyOther: Beer (alcoholic)|Other: Placebo (non-alcoholic beer)https://ClinicalTrials.gov/show/NCT02318823
1875718757Influence of the Neuromuscular Blockade on Mask VentilationRecruitingNo Results AvailableComplication of Ventilation Therapy|Observation of Neuromuscular BlockDrug: Rocuronium 0.3 mg/kg|Drug: Rocuronium 0.6 mg/kg|Drug: Rocuronium 0.9 mg/kg|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02318810
1875818758Optimizing Behavioral Health Homes for Adults With Serious Mental IllnessActive, not recruitingNo Results AvailableChronic Disease|Mental Health|Behavioral Health|Cardiovascular Disease|Diabetes Mellitus Type 2|Substance-related Disorders|Vascular DiseasesBehavioral: Patient Self-Directed Care|Behavioral: Provider-Supported Integrated Carehttps://ClinicalTrials.gov/show/NCT02318797
1875918759Carfilzomib for the Treatment of Patients With Advanced Neuroendocrine CancersRecruitingNo Results AvailableNeuroendocrine CancerDrug: Carfilzomibhttps://ClinicalTrials.gov/show/NCT02318784
1876018760Radiation Therapy and MK-3475 for Patients With Recurrent/Metastatic Head and Neck Cancer, Renal Cell Cancer, Urothelial Cancer, Melanoma, and Non-Small Cell Lung CancerRecruitingNo Results AvailableHead and Neck Squamous Cell Carcinoma|Metastatic Renal Cell Cancer|Recurrent Head and Neck Carcinoma|Recurrent Non-Small Cell Lung Carcinoma|Recurrent Renal Cell Carcinoma|Recurrent Skin Carcinoma|Stage III Renal Cell Cancer|Stage IV Non-Small Cell Lung CRadiation: Radiation Therapy (RT)|Drug: MK-3475https://ClinicalTrials.gov/show/NCT02318771
1876118761Pharmacokinetic Interaction of Oral Treprostinil and Ethanol in Healthy VolunteersCompletedNo Results AvailableHealthyDrug: UT-15C|Other: ethanolhttps://ClinicalTrials.gov/show/NCT02318758
1876218762Preventing Health Disparities in Hispanic YouthCompletedNo Results AvailableADHD|Conduct Disorder|Depression|Family DysfunctionBehavioral: Culturally Informed Family Treatment for Adolescents|Behavioral: Individual Treatmenthttps://ClinicalTrials.gov/show/NCT02318745
1876318763Evaluation of California's Armed and Prohibited Persons SystemNot yet recruitingNo Results AvailableViolenceBehavioral: APPS interventionhttps://ClinicalTrials.gov/show/NCT02318732
1876418764DS-5565 Phase III Study for Post-herpetic NeuralgiaRecruitingNo Results AvailablePost-Herpetic NeuralgiaDrug: placebo|Drug: DS-5565https://ClinicalTrials.gov/show/NCT02318719
1876518765DS-5565 Phase III Study for Diabetic Peripheral Neuropathic PainRecruitingNo Results AvailableDiabetic Peripheral Neuropathic PainDrug: DS-5565|Drug: placebohttps://ClinicalTrials.gov/show/NCT02318706
1876618766Efficacy of Sitagliptin and Glibenclamide on the Glucose Variability in Japanese Participants With Type 2 Diabetes Mellitus (MK-0431-355)RecruitingNo Results AvailableType 2 Diabetes MellitusDrug: Sitagliptin|Drug: Glibenclamidehttps://ClinicalTrials.gov/show/NCT02318693
1876718767Follow Home Visits After DischargeCompletedNo Results AvailableDischarge Planning|Readmission|Hospital|Frail Elderly PatientsOther: Review of follow home visits after discharge from Nykøbing Falster Hospitalhttps://ClinicalTrials.gov/show/NCT02318680
1876818768Correlation of Soluble ST2 With Golimumab (MK-8259) Response in Participants With Ulcerative Colitis (UC) (MK-8529-022).RecruitingNo Results AvailableColitis, UlcerativeBiological: Golimumabhttps://ClinicalTrials.gov/show/NCT02318667
1876918769Ice Versus EMLA for Pain in Laser Hair RemovalActive, not recruitingNo Results AvailableHair RemovalOther: Ice Pack|Drug: Topical EMLA creamhttps://ClinicalTrials.gov/show/NCT02318654
1877018770Measurement of the Oxygen Saturation in the Retinal Vessels With OxymapRecruitingNo Results AvailableChorioretinal Disorders in Diseases Classified ElsewhereDevice: oximetryhttps://ClinicalTrials.gov/show/NCT02318641
1877118771Advanced Approach to Arterial StiffnessRecruitingNo Results AvailableArterial StiffnessDevice: Cardio Ankle Vascular Index (CAVI) of the Vasera system VS1500Nhttps://ClinicalTrials.gov/show/NCT02318628
1877218772Immediate Axillary Plasty With a Pedicled Muscle Flap for Breast Cancer Related Lymphedema PreventionNot yet recruitingNo Results AvailableLymphedema|Breast NeoplasmProcedure: Immediate Axillary Plastyhttps://ClinicalTrials.gov/show/NCT02318615
1877318773Cannabidiol Oral Solution as an Adjunctive Treatment for Treatment-resistant Seizure DisorderNot yet recruitingNo Results AvailableSeizuresDrug: Cannabidiol Oral Solutionhttps://ClinicalTrials.gov/show/NCT02318602
1877418774Phase I of Eribulin and Oral Irinotecan for Relapsed or Refractory Solid TumorsNot yet recruitingNo Results AvailableSolid TumorDrug: Irinotecan + Eribulinhttps://ClinicalTrials.gov/show/NCT02318589
1877518775Computerized Cognition Testing and Cognitive Motor Interference in MSRecruitingNo Results AvailableMultiple SclerosisOther: Cognitive Traininghttps://ClinicalTrials.gov/show/NCT02318576
1877618776Cannabidiol Oral Solution as an Adjunctive Therapy for Treatment of Subjects With Inadequately Controlled Dravet SyndromeNot yet recruitingNo Results AvailableDravet SyndromeDrug: Cannabidiol Oral Solution|Drug: Placebo Solutionhttps://ClinicalTrials.gov/show/NCT02318563
1877718777Safety of MRI for Patients With Non-MRI Conditional Pacemakers and ICD Non-MRI Conditional Pacemakers and ICDRecruitingNo Results AvailableMRI Scans|Magnetic Resonance Imaging|Pacemaker|Implantable Cardioverter DefibrillatorOther: MRI Scanhttps://ClinicalTrials.gov/show/NCT02318550
1877818778Cannabidiol Oral Solution as an Adjunctive Therapy for Treatment of Subjects With Inadequately Controlled Lennox-Gastaut SyndromeNot yet recruitingNo Results AvailableLennox-Gastaut SyndromeDrug: Cannabidiol Oral Solution|Drug: Placebo Solutionhttps://ClinicalTrials.gov/show/NCT02318537
1877918779Clinical Impact of Fungal Domestic Environmental Exposure on COPD PatientsRecruitingNo Results AvailableCOPD|Pulmonary Fungal Diseases|Environmental Exposurehttps://ClinicalTrials.gov/show/NCT02318524
1878018780An Investigation of ReNuâ„¢ Knee Injection in Patients With OsteoarthritisRecruitingNo Results AvailableOsteoarthritisProcedure: Knee injection|Device: ReNu amniotic allograft|Device: placebo saline|Device: Hyaluronic Acidhttps://ClinicalTrials.gov/show/NCT02318511

* Görseller ve İçerik tekif hakkına sahip olabilir